Skip to content

Clinical trials

Observational Arthritis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis Phase: Observational Country / region: United States Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20033
20053
20062
20073
20083
20096
20103
20116
20125
20134
20142
20154
20163
20172
20181
20191
20202
20214
20221
20233
20243
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting11
Terminated10
Unknown status7
Active, not recruiting4
Enrolling by invitation2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)7
Zimmer Biomet7
Smith & Nephew, Inc.6
Duke University5
National Center for Research Resources (NCRR)4
Northwest Surgical Specialists, Vancouver2
Stanford University2
University of Nebraska2
Washington University School of Medicine2
American College of Rheumatology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis76
Osteoarthritis19
Arthritis, Rheumatoid14
Osteoarthritis, Knee7
Joint Diseases6
Osteonecrosis6
Spondylitis, Ankylosing6
Arthritis, Juvenile5
Chronic Pain5
Lupus Erythematosus, Systemic5

Trials

Showing 1 to 25 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.